TAGLN and breast carcinoma: To confirm downregulation of TAGLN in both protein and mRNA levels in other independent breast tumor tissue panels of larger sample sizes with pathological information, expression of TAGLN was examined in a breast cancer tissue array by IHC staining (BioChain, Cat.No:Z7020005), and in an independent cDNA panel by qRT-PCR (OriGene, Cat.No:BCRT101).